1. FRI0198 Expressions of immune response related genes were normalised after tocilizumab treatment in rheumatoid arthritis (RA) patients. (23rd January 2014) Authors: Nishimoto, N.; Lee, H.-M.; Murakami, M.; Aoki, C.; Li, Y.; Matsutani, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0206 Abatacept (CTLA4-IG) suppresses T cell activation and reduces TH17 cells as well as plasma IL-6 in patients with rheumatoid arthritis. (23rd January 2014) Authors: Matsutani, T.; Li, Y.; Murakami, M.; Lee, H.-M.; Aoki, C.; Sekiguchi, M.; Matsui, K.; Kitano, M.; Namiki, M.; Ohmura, K.; Murakami, K.; Fujii, T.; Kuroiwa, T.; Shimaoka, Y.; Nakahara, H.; Maeda, K.; Irimajiri, S.; Funauchi, M.; Imura, Y.; Ikawa, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0101 Abatacept Treatment Suppresses T Cell Activation in Anti-Cyclic Citrullinated Peptide Antibody (ACPA) Positive RA Patients but not in Acpa Negative RA Patients. (23rd January 2014) Authors: Matsutani, T.; Murakami, M.; Sekiguchi, M.; Matsui, K.; Kitano, M.; Namiki, M.; Ohmura, K.; Imura, Y.; Fujii, T.; Kuroiwa, T.; Nakahara, H.; Hika, S.; Maeda, K.; Nozaki, Y.; Funauchi, M.; Murakami, K.; Ikawa, T.; Irimajiri, S.; Nampei, A.; Azuma, T. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0121 Changes in Cytokine Profiles in Rheumatoid Arthritis Patients During Abatacept Treatment. (23rd January 2014) Authors: Murakami, M.; Matsutani, T.; Sekiguchi, M.; Matsui, K.; Kitano, M.; Namiki, M.; Ohmura, K.; Imura, Y.; Fujii, T.; Kuroiwa, T.; Nakahara, H.; Higa, S.; Maeda, K.; Nozaki, Y.; Funauchi, M.; Murakami, K.; Ikawa, T.; Irimajiri, S.; Nampei, A.; Azuma, T. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0378 Interleukin-6 blocking therapy by tocilizumab in patients with multicentric castleman's disease results in a significant decrease in serum levels of IgG4 and IGE. (23rd January 2014) Authors: Murakami, M.; Matsutani, T.; Aoki, C.; Lee, H.-M.; Li, Y.; Nishimoto, N. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗